L19IL2/L19TNF not checked

Philogen S.p.A.

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
5 active
6 in total · 6 in the EU

What this is

How it works
How it works isn't classified yet
How it’s given
“Patients will receive intratumoral administrations into injectable cutaneous, subcutaneous, and nodal tumors of Daromun once weekly for up to 4 weeks.”In the company’s words, NCT03567889 on ClinicalTrials.gov
Tested for
Locally Advanced Basal Cell Carcinoma (2 trials), Melanoma Stage IIIB, Melanoma Stage IIIC, Melanoma Stage IIID, Melanoma Stage III, Melanoma Stage IV, Locally Advanced Cutaneous Squamous Cell Carcinoma
Main trialPhase 3
“The trial aims to evaluate the efficacy of Daromun neoadjuvant treatment followed by surgery and adjuvant therapy to improve in a statistically significant manner the recurrence-free survival (RFS) of Stage IIIB/C/D melanoma patients with respect to the standard of care (surgery and adjuvant therapy).”In the company’s words, NCT03567889 on ClinicalTrials.gov
Other names
Daromun · bifikafusp alfa/onfekafusp alfa

Other drugs for Locally Advanced Basal Cell Carcinoma

All 14 drugs for Locally Advanced Basal Cell Carcinoma

Coming up5

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials6

TrialPhaseCompletesWhat it tests
Phase 3Recruiting Dec 2027 Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
Phase 2Recruiting Jul 2028 Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination With Pembrolizumab, in Unresectable Melanoma Patients
Phase 2Recruiting Feb 2031 L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC)
Phase 2Recruiting Feb 2031 L19IL2/L19TNF in Patients With Cutaneous Squamous Cell Carcinoma
Phase 2Recruiting Feb 2031 L19IL2/TNF in Patients With Basal Cell Carcinoma
Phase 2Unknown Jun 2024 L19IL2/L19TNF in Skin Cancer Patients
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow L19IL2/L19TNF

Following is part of Solo: you see every change to L19IL2/L19TNF the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in